INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 17 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $719,000 | +29.1% | 155,683 | -2.2% | 0.01% | +14.3% |
| Q4 2018 | $557,000 | -65.3% | 159,133 | 0.0% | 0.01% | -53.3% |
| Q3 2018 | $1,604,000 | +39.2% | 159,133 | 0.0% | 0.02% | +36.4% |
| Q2 2018 | $1,152,000 | +19.9% | 159,133 | +0.0% | 0.01% | +10.0% |
| Q1 2018 | $961,000 | -41.6% | 159,107 | -7.0% | 0.01% | -33.3% |
| Q4 2017 | $1,646,000 | +2.8% | 171,071 | -5.1% | 0.02% | +15.4% |
| Q3 2017 | $1,601,000 | -29.8% | 180,309 | 0.0% | 0.01% | -31.6% |
| Q2 2017 | $2,281,000 | +19.2% | 180,309 | -1.0% | 0.02% | +18.8% |
| Q1 2017 | $1,914,000 | +14.2% | 182,135 | 0.0% | 0.02% | +14.3% |
| Q4 2016 | $1,676,000 | -21.9% | 182,135 | 0.0% | 0.01% | -17.6% |
| Q3 2016 | $2,147,000 | -8.9% | 182,135 | 0.0% | 0.02% | -15.0% |
| Q2 2016 | $2,357,000 | -19.1% | 182,135 | 0.0% | 0.02% | -28.6% |
| Q1 2016 | $2,912,000 | -44.2% | 182,135 | 0.0% | 0.03% | -44.0% |
| Q4 2015 | $5,215,000 | -1.5% | 182,135 | -2.1% | 0.05% | -9.1% |
| Q3 2015 | $5,295,000 | -21.7% | 186,036 | -1.2% | 0.06% | -33.7% |
| Q2 2015 | $6,761,000 | +23.6% | 188,236 | +100.0% | 0.08% | +33.9% |
| Q1 2015 | $5,470,000 | +37.8% | 94,118 | 0.0% | 0.06% | +34.8% |
| Q4 2014 | $3,969,000 | – | 94,118 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 788,175 | $10,199,000 | 4.68% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,987,313 | $116,296,000 | 2.40% |
| Antipodean Advisors LLC | 305,294 | $3,951,000 | 2.39% |
| Freshford Capital Management, LLC | 475,984 | $6,159,000 | 1.81% |
| Folger Hill Asset Management LP | 1,597,945 | $20,677,000 | 1.61% |
| JW Asset Management, LLC | 150,638 | $1,949,000 | 1.55% |
| 12 West Capital Management LP | 623,791 | $8,072,000 | 1.30% |
| Orbimed Advisors | 4,688,240 | $60,666,000 | 0.63% |
| CYPRESS FUNDS LLC | 135,584 | $1,754,000 | 0.41% |
| Rock Springs Capital Management LP | 365,500 | $4,730,000 | 0.35% |